Weiss Asset Management LP Buys Shares of 113,695 Aveanna Healthcare Holdings Inc. $AVAH

Weiss Asset Management LP purchased a new position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 113,695 shares of the company’s stock, valued at approximately $732,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in AVAH. AQR Capital Management LLC boosted its position in shares of Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after purchasing an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Aveanna Healthcare by 8.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after buying an additional 25,974 shares during the last quarter. Jane Street Group LLC increased its position in Aveanna Healthcare by 522.0% during the 1st quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after buying an additional 63,010 shares in the last quarter. Creative Planning increased its position in Aveanna Healthcare by 15.1% during the 2nd quarter. Creative Planning now owns 47,025 shares of the company’s stock valued at $246,000 after buying an additional 6,171 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in Aveanna Healthcare by 65.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock valued at $828,000 after buying an additional 62,348 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective on the stock in a report on Wednesday, June 3rd. Barclays increased their price objective on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a research report on Thursday, July 9th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Finally, Truist Financial boosted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Aveanna Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $10.78.

Aveanna Healthcare Stock Performance

Shares of AVAH stock opened at $9.67 on Tuesday. The business has a fifty day moving average of $8.24 and a 200 day moving average of $7.68. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.73 and a 1 year high of $10.32. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. The firm has a market capitalization of $2.11 billion, a price-to-earnings ratio of 8.19, a price-to-earnings-growth ratio of 0.94 and a beta of 1.89.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.05. The business had revenue of $647.91 million for the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business’s revenue was up 15.9% on a year-over-year basis. As a group, research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Insider Transactions at Aveanna Healthcare

In related news, insider Patrick A. Cunningham sold 125,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total value of $948,750.00. Following the sale, the insider owned 212,755 shares in the company, valued at $1,614,810.45. This represents a 37.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Paul R. Vigano sold 3,000,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total value of $24,030,000.00. Following the completion of the sale, the insider owned 190,130 shares in the company, valued at approximately $1,522,941.30. This represents a 94.04% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 31,305,664 shares of company stock worth $215,555,910. 5.30% of the stock is owned by company insiders.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.